Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Viatris has the lowest figure of the 61 pharmaceutical companies ranked by earnings, at -ZAR 60.6B, followed by Insmed (-ZAR 22B) and Summit Therapeutics (-ZAR 18.6B). Figures as of 18 Nov 2026, 17:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Viatris-ZAR 60.6B
- Median
- ZAR 1B
- Combined market value
- ZAR 87.79T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ViatrisVTRS · Health Care | -ZAR 60.6B | ZAR 410.3B | ZAR 357.87 | 1.44% up | 96% up | ||
| 2 | InsmedINSM · Health Care | -ZAR 22B | ZAR 457.9B | ZAR 2,087.43 | 0.70% down | 40% down | ||
| 3 | Summit TherapeuticsSMMT · Health Care | -ZAR 18.6B | ZAR 147.3B | ZAR 184.15 | 0.05% up | 36% down | ||
| 4 | Takeda PharmaceuticalTAK · Health Care | -ZAR 16.5B | ZAR 1.18T | ZAR 369.17 | 1.11% down | 54% up | ||
| 5 | CytokineticsCYTK · Health Care | -ZAR 13.5B | ZAR 124.1B | ZAR 890.92 | 0.01% down | 20% down | ||
| 6 | BridgeBio PharmaBBIO · Health Care | -ZAR 12.6B | ZAR 262B | ZAR 1,344.79 | 1.50% up | 17% up | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | -ZAR 6.6B | ZAR 79.3B | ZAR 475.95 | 2.34% up | 64% down | ||
| 8 | ABIVAXABVX · Health Care | -ZAR 6.4B | ZAR 126.9B | ZAR 1,449.41 | 2.34% up | 27% down | ||
| 9 | Jazz PharmaceuticalsJAZZ · Health Care | -ZAR 6.1B | ZAR 272.9B | ZAR 4,251.55 | 2.39% up | 37% up | ||
| 10 | Cogent BiosciencesCOGT · Health Care | -ZAR 5.7B | ZAR 84.9B | ZAR 487.85 | 1.54% up | 20% down | ||
| 11 | Praxis Precision MedicinesPRAX · Health Care | -ZAR 5.2B | ZAR 148.8B | ZAR 5,322.82 | 1.15% up | 61% up | ||
| 12 | Roivant SciencesROIV · Health Care | -ZAR 5.2B | ZAR 483.5B | ZAR 667.35 | 0.06% down | 90% up | ||
| 13 | Legend BiotechLEGN · Health Care | -ZAR 5.1B | ZAR 54.3B | ZAR 279.81 | 0.68% up | 42% down | ||
| 14 | Madrigal PharmaceuticalsMDGL · Health Care | -ZAR 5B | ZAR 162.9B | ZAR 7,013.66 | 3.65% down | 24% down | ||
| 15 | Ascendis PharmaASND · Health Care | -ZAR 4.4B | ZAR 307.2B | ZAR 4,683.20 | 0.11% up | 28% up | ||
| 16 | Elanco Animal HealthELAN · Health Care | -ZAR 4B | ZAR 231.3B | ZAR 462.67 | 3.75% up | 20% up | ||
| 17 | Rhythm PharmaceuticalsRYTM · Health Care | -ZAR 3.4B | ZAR 142.4B | ZAR 2,054.57 | 2.14% up | 13% up | ||
| 18 | Definium TherapeuticsDFTX · Health Care | -ZAR 3.2B | ZAR 68.7B | ZAR 502.17 | 0.92% down | 169% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -ZAR 3.2B | ZAR 121.4B | ZAR 2,307.04 | 1.63% down | 7% down | ||
| 20 | Edgewise TherapeuticsEWTX · Health Care | -ZAR 2.9B | ZAR 79.1B | ZAR 722.29 | 0.40% down | 88% up | ||
| 21 | Dianthus TherapeuticsDNTH · Health Care | -ZAR 2.8B | ZAR 84.8B | ZAR 1,505.13 | 0.31% up | 113% up | ||
| 22 | Spyre TherapeuticsSYRE · Health Care | -ZAR 2.7B | ZAR 159.6B | ZAR 1,680.31 | 3.83% up | 286% up | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | -ZAR 2.2B | ZAR 141.2B | ZAR 2,163.60 | 0.60% up | 46% up | ||
| 24 | ErascaERAS · Health Care | -ZAR 2.1B | ZAR 80.5B | ZAR 229.44 | 4.25% down | 403% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -ZAR 1.8B | ZAR 114.7B | ZAR 1,690.49 | 1.74% up | 241% up | ||
| 26 | Belite BioBLTE · Health Care | -ZAR 1.3B | ZAR 111B | ZAR 2,733.04 | 0.45% up | 31% up | ||
| 27 | VeradermicsMANE · Health Care | -ZAR 1.2B | ZAR 90.3B | ZAR 2,138.93 | 1.31% down | 233% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | -ZAR 440.7M | ZAR 84.8B | ZAR 883.76 | 0.25% up | 44% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | -ZAR 403M | ZAR 103.7B | ZAR 1,588.63 | 0.15% up | 31% up | ||
| 30 | Arrowhead PharmaceuticalsARWR · Health Care | -ZAR 28.1M | ZAR 106.2B | ZAR 751.27 | 1.30% up | 10% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 1B | ZAR 129.5B | ZAR 1,647.88 | 0.44% up | 126% up | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 1.2B | ZAR 132.1B | ZAR 379.17 | 4.07% up | 83% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | ZAR 1.7B | ZAR 129.1B | ZAR 1,179.18 | 2.45% down | 8% down | ||
| 34 | Ligand PharmaceuticalsLGND · Health Care | ZAR 2.1B | ZAR 103.8B | ZAR 5,187.49 | 2.35% up | 43% up | ||
| 35 | AlkermesALKS · Health Care | ZAR 4.2B | ZAR 135.8B | ZAR 808.37 | 3.10% up | 58% up | ||
| 36 | BeOne MedicinesONC · Health Care | ZAR 4.9B | ZAR 799.3B | ZAR 6,997.61 | 1.84% down | 17% up | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 5.4B | ZAR 351.5B | ZAR 2,624.54 | 2.79% down | 66% down | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 6B | ZAR 202.6B | ZAR 1,046.17 | 3.65% up | 11% up | ||
| 39 | GrifolsGRFS · Health Care | ZAR 7.7B | ZAR 99.4B | ZAR 146.11 | 1.85% down | 1% up | ||
| 40 | TG TherapeuticsTGTX · Health Care | ZAR 7.7B | ZAR 172.7B | ZAR 1,142.87 | 5.65% up | 107% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 7.9B | ZAR 215.9B | ZAR 259.02 | 1.52% up | 5% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | ZAR 11.8B | ZAR 87.1B | ZAR 1,043.16 | 0.18% up | 20% down | ||
| 43 | Royalty PharmaRPRX · Health Care | ZAR 13.3B | ZAR 687.5B | ZAR 1,195.65 | 0.92% up | 78% up | ||
| 44 | GenmabGMAB · Health Care | ZAR 16.6B | ZAR 547.8B | ZAR 888.42 | 0.89% down | 70% up | ||
| 45 | United TherapeuticsUTHR · Health Care | ZAR 23B | ZAR 426.9B | ZAR 10,022.89 | 0.53% down | 23% up | ||
| 46 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 24.3B | ZAR 851.1B | ZAR 729.45 | 0.79% down | 74% up | ||
| 47 | ZoetisZTS · Health Care | ZAR 46.1B | ZAR 594.4B | ZAR 1,462.87 | 1.58% up | 29% down | ||
| 48 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 68.2B | ZAR 2.35T | ZAR 9,253.93 | 0.42% up | 27% up | ||
| 49 | AbbVieABBV · Health Care | ZAR 72.9B | ZAR 8.78T | ZAR 4,966.16 | 1.69% down | 26% up | ||
| 50 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 77.7B | ZAR 1.69T | ZAR 16,375.15 | 0.89% down | 36% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | ZAR 112.5B | ZAR 3.13T | ZAR 1,804.43 | 0.11% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | ZAR 121.7B | ZAR 2.12T | ZAR 1,034.88 | 2.22% down | 34% up | ||
| 53 | GSKGSK · Health Care | ZAR 130.9B | ZAR 1.69T | ZAR 841.67 | 0.91% down | 6% up | ||
| 54 | PfizerPFE · Health Care | ZAR 134.1B | ZAR 2.77T | ZAR 485.87 | 1.07% down | 14% up | ||
| 55 | SanofiSNY · Health Care | ZAR 149.5B | ZAR 1.96T | ZAR 816.39 | 0.43% down | 4% down | ||
| 56 | AstraZenecaAZN · Health Care | ZAR 176.4B | ZAR 4.8T | ZAR 3,095.83 | 1.54% down | 2% up | ||
| 57 | NovartisNVS · Health Care | ZAR 241.2B | ZAR 5.08T | ZAR 2,691.12 | 1.97% down | 25% up | ||
| 58 | Novo NordiskNVO · Health Care | ZAR 262.2B | ZAR 3.01T | ZAR 682.96 | 2.73% down | 17% down | ||
| 59 | Merck & CoMRK · Health Care | ZAR 314.9B | ZAR 5.9T | ZAR 2,394.84 | 3.17% down | 51% up | ||
| 60 | Eli LillyLLY · Health Care | ZAR 356.1B | ZAR 21.37T | ZAR 23,988.10 | 1.77% down | 35% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | ZAR 462.4B | ZAR 11.47T | ZAR 4,762.95 | 0.93% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2508 ZAR).
Questions and answers
Which pharmaceutical companies have the lowest earnings?
Viatris (-ZAR 60.6B), Insmed (-ZAR 22B) and Summit Therapeutics (-ZAR 18.6B) have the lowest earnings of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 17:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of ZAR 87.79T as of 18 Nov 2026, 17:47 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.